Show All Hide All

Marc N. Casper , President and Chief Executive Officer, Thermo Fisher Scientific

Marc Casper has been President and Chief Executive Officer of Thermo Fisher Scientific since October 2009. He joined the company in 2001 as President of the Life Sciences sector of Thermo Electron. He was named Senior Vice President in 2003, and in 2005 was given responsibility for all of the company’s operating divisions. After the merger creating Thermo Fisher Scientific in 2006, Marc was named President, Analytical Technologies, and in 2008 was named Chief Operating Officer.

Prior to joining Thermo Fisher, Marc served as President, Chief Executive Officer and a director of Kendro Laboratory Products. Before Kendro, he worked for clinical diagnostics provider Dade Behring Inc., where he served as President – Americas. Marc began his career at Bain & Company as a strategy consultant and later joined Bain Capital.

Marc received an MBA with high distinction from Harvard Business School and is a graduate of Wesleyan University, where he received a bachelor’s degree in economics. Marc serves on the Brigham & Women’s Hospital Board of Trustees, US-China Business Council and the Massachusetts Math & Science Initiative. He is also a member of the Business Roundtable, an association of CEOs of leading U.S. companies. He is currently a director of U.S. Bancorp and was previously a director of the Advisory Board Company and Zimmer Holdings.

Mark P. Stevenson , Executive Vice President and President, Life Sciences Solutions

Mark joined the company as Executive Vice President and President, Life Sciences Solutions, in 2014 through the acquisition of Life Technologies. Prior to that, he served as President and Chief Operating Officer of Life Technologies. Mark was previously President and Chief Operating Officer of Applied Biosystems before the merger with Invitrogen Corporation in 2008 that created Life Technologies.

At Applied Biosystems, Mark held roles of increasing responsibility in Europe and Japan. He moved to the U. S. in 2004 to establish the Applied Markets Division and, in 2006, was named President of the Molecular and Cellular Biology Division. He has more than 20 years of experience in sales, marketing and international executive management.

Mark received his MBA from Henley Management School in the U.K. and his bachelor’s degree in chemistry from the University of Reading, also in the U.K. He serves as an executive committee board member of the life science association, BIOCOM.

Peter M. Wilver , Executive Vice President and Chief Administrative Officer

Pete joined the company in October 2000 as Vice President of Financial Operations, with responsibility for integrating company-wide financial operations and systems, and establishing a robust financial analysis and reporting process. In 2004, he was named Chief Financial Officer, and in that role led the company’s tax, treasury, financial reporting and investor relations functions for 11 years. In August 2015, Pete became Executive Vice President and Chief Administrative Officer, with responsibility for the company’s global business services, human resources and legal functions.

Pete began his career at General Electric, where he worked for 13 years in various finance roles. Subsequently, he joined Grimes Aerospace Company and then Honeywell International (formerly Allied Signal), where he served as Vice President and Chief Financial Officer of the Electronic Materials Division before joining Thermo Fisher.

Pete is a summa cum laude graduate of The Ohio State University, where he earned a bachelor's degree in business administration with a major in accounting. Pete is also a certified public accountant and serves on the board of CIRCOR International, Inc. (CIR).

Stephen Williamson , Senior Vice President and Chief Financial Officer

In August 2015, Stephen was named Senior Vice President and Chief Financial Officer, responsible for the company’s tax, treasury, financial reporting and investor relations functions. He joined the company in 2001 as Vice President, European Financial Operations, based in the U.K., and oversaw the company’s integration activities across Europe. In 2004, Stephen moved to the U.S. and held finance leadership roles for a number of the company’s operating businesses. In 2008, he became Vice President of Financial Operations for Thermo Fisher Scientific and led the finance support function for all of the company’s businesses.

Stephen joined Thermo Fisher from Honeywell International (formerly AlliedSignal), where he served as Vice President and Chief Financial Officer, Asia-Pacific, in Singapore and held other finance roles in corporate development and operational finance. He began his career with Price Waterhouse in the transaction support group and the audit practice, working in both London and New York.

Stephen holds a bachelor's degree in accounting and finance from the University of Wales and is a member of the Institute of Chartered Accountants of England and Wales.

Patrick M. Durbin , Senior Vice President and President, Specialty Diagnostics

Patrick joined the company in 2006 as General Manager, North America, for the Clinical Services business and assumed global leadership of that business in 2008. In 2010, he became President of BioPharma Services, and in October 2015, Patrick was named Senior Vice President and President, Specialty Diagnostics.

Prior to joining Thermo Fisher, Patrick worked for 16 years at Covance, where he held a number of general management, operational, sales and corporate roles. Patrick served on the corporate team that launched Covance as a public company when it spun off from Corning, Inc.

Patrick received his MBA and a bachelor’s degree in biology from St. Joseph’s University in Philadelphia, Pennsylvania.

Gregory J. Herrema , Senior Vice President and President, Customer Channels

Greg joined the company in January 2002 as President, Environmental Instruments. He was named President, Scientific Instruments, in May 2006 and became Senior Vice President and President, Analytical Instruments, two years later. In 2012, Greg was named President, Biosciences, and in January 2014, he became Senior Vice President and President of the company’s Customer Channels business.

Prior to joining Thermo Fisher, Greg spent 14 years at General Electric, including two years at Borg Warner Chemicals (acquired by GE Plastics). While at GE, his career progressed through multiple sales, marketing and general management roles within the Plastics and Transportation Systems divisions.

Greg holds an MBA from Harvard Business School and bachelor’s degrees in chemical engineering from Virginia Tech and the University of Exeter. Greg is past Chairman and current member of the Board of Advisors of ALDA (Analytical, Life Science & Diagnostics Association).

Thomas W. Loewald , Senior Vice President and Chief Commercial Officer

Tom joined the company in 2002 as Vice President of Sales and Services, and General Manager of the Explosives Detection business unit within the Environmental Instruments Division (EID). From 2004 to 2006, he was Vice President and General Manager of EID’s Radiation Measurement and Security Instruments business unit, and in 2006 he became President of EID. In 2008, Tom was named President of the Laboratory Equipment Division within the Laboratory Products Group (LPG) and became Senior Vice President and President of LPG in 2012. Two years later, Tom was named President of the Analytical Instruments Group, and on January 1, 2016, he became Senior Vice President and Chief Commercial Officer, with responsibility for our corporate customer-focused functions, Unity Lab Services, the BioPharma Services Division and EMEA.

Prior to joining Thermo Fisher, Tom was Vice President of Sales and Marketing for Tyco International. Earlier in his career, he worked in a variety of management roles for General Electric and as a Financial Analyst for Goldman, Sachs & Co.

Tom received his MBA from the Amos Tuck School of Business Administration at Dartmouth and holds a bachelor’s degree in economics from Middlebury College. He serves on the board of the National Association of Manufacturers.

Frederick M. Lowery , Senior Vice President and President, Laboratory Products

Fred joined the company in 2005 as head of operations for the Molecular BioProducts business of Fisher Scientific. He also led the transformation of the new product development process. When Fisher Scientific merged with Thermo Electron in 2006, Fred was named Vice President and General Manager of the Chromatography Consumables and Specialty Glass business.

In 2010, he became Vice President and General Manager of the Life Science Research business, and in 2011 was named President, Laboratory Consumables. In January 2014, Fred was named Senior Vice President and President, Laboratory Products.

Prior to joining Thermo Fisher, Fred was a Product Director at Maytag Corporation and also served as Director of Lean Sigma and Supply Management for the company. Earlier in his career, he was a Design Release Engineer at General Motors.

Fred holds a master’s degree in manufacturing management from Kettering University (formerly General Motors Institute of Engineering and Management) and a bachelor’s degree in mechanical engineering from Tennessee Technological University. He serves on the Boys and Girls Club Board of Directors in Lee County, Alabama.

Dan Shine , Senior Vice President and President, Analytical Instruments

Dan joined Thermo Fisher Scientific in 1998 as a controller, and over the next four years held a number of leadership positions within finance and operations. In June 2002, he was appointed to lead the company’s Elemental Analysis product line and a year later became Vice President and General Manager of that business. In 2007, he was promoted to President of Process Instruments, and in 2011 became President of the Chemical Analysis business. Dan was named President of Chromatography and Mass Spectrometry in 2012, and on January 1, 2016, became Senior Vice President and President of Analytical Instruments.

Prior to joining Thermo Fisher, Dan worked for international accounting firm Arthur Andersen for eight years. He holds a bachelor’s degree in economics from Wesleyan University and a master’s degree in professional accounting from the University of Hartford.

Andrew J. Thomson , Senior Vice President and President, EMEA

Andy joined Thermo Fisher Scientific in 2009 as Vice President and General Manager, North America, for the Microbiology business. He was promoted to President, Clinical Diagnostics, in October 2009, and was named Senior Vice President and President, Specialty Diagnostics, in February 2012. In October 2015, Andy became Senior Vice President and President of Europe, the Middle East and Africa.

Prior to joining Thermo Fisher, Andy worked for 20 years in the diagnostics industry, including nine years with Dade Behring (now Siemens Diagnostics), where he served in various marketing roles, and ultimately became Vice President of Marketing for the company’s North America region. Andy then joined Roche Diagnostics, where, during his six-year tenure, he was Senior Vice President of Global Marketing for Centralized Diagnostics in Germany and later led all commercial activities for the Professional Diagnostics group in the U.S.

Andy holds an honors degree in economics from Queen’s University in Kingston, Canada.

Seth H. Hoogasian , Senior Vice President and General Counsel

Seth joined the company in 1990 as Senior Counsel and became General Counsel in 1992. Prior to joining Thermo Fisher, Seth served as a partner in the Baltimore, Maryland-based law firm of Weinberg and Green, and as an associate at Shaw, Pittman, Potts & Trowbridge in Washington, D.C. Seth is a graduate of Duke University School of Law with a juris doctorate with distinction, and received his Bachelor of Science degree with distinction in mechanical engineering from Cornell University.

Thermo Fisher Scientific At a Glance

$17 billion in annual revenues

50,000+ Employees

50 Countries

Premier Brands

– Thermo Scientific

– Applied Biosystems

– Invitrogen

– Fisher Scientific

– Unity Lab Services

Read more

NYSE: TMO (Common Stock)Jan 19, 2017 11:40 AM

Exchange NYSE (US Dollar)NYSE

Price 144.15

Change -0.51  (-0.35%)

Volume 367,146

% Change

Intraday High 144.48

52 Week High 160.68

Intraday Low 143.44

52 Week Low 119.75

Today's Open 144.38

Previous Close 144.66

Minimum 20 minute delay

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.

The world leader in serving science